Understanding why Black and Hispanic patients with Hodgkin lymphoma have lower survival rates
Official title: Determining Barriers Leading to Inferior Survival for Black and Hispanic Patients with Hodgkin Lymphoma: A Patient-Centered Study
Funded at University of Florida · NIH-11030387 · Data updated 2026-11-12
This study is looking into why Black and Hispanic patients with Hodgkin lymphoma have lower survival rates, and it aims to find out what challenges they face so that we can create better support and treatment options for them.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project start | February 1, 2025 |
| Project end | January 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $589,591 |
| NIH project number | 1R37CA288560-01A1 |
| Project ID | NIH-11030387 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Black and Hispanic individuals diagnosed with Hodgkin lymphoma across all age groups.
✕Less likely to help
Patients who are not Black or Hispanic or those with other types of cancer may not benefit from this research.
What this research studies
This research investigates the reasons behind the lower survival rates of Black and Hispanic patients diagnosed with Hodgkin lymphoma. By analyzing comprehensive patient data, including social factors and treatment outcomes, the study aims to identify specific barriers that contribute to these disparities. The research will utilize advanced databases to link patient records and treatment histories, focusing on how these factors vary across different age groups. Ultimately, the goal is to develop targeted interventions to improve survival outcomes for these populations.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and support systems for Black and Hispanic patients with Hodgkin lymphoma.
How similar studies have gone: Previous research has shown that addressing social determinants of health can significantly improve outcomes for marginalized patient populations, suggesting potential success for this approach.
Where this research is happening
-
University of Florida
Gainesville, United States Active
Researchers
- Principal investigator: Mailhot, Raymond B — University of Florida
- Study coordinator: Mailhot, Raymond B
Related research
Other NIH-funded projects on the same topics.
-
Understanding why Black and Hispanic Hodgkin lymphoma patients have worse survival
A patient-centered study to uncover social and care factors that contribute to lower survival among Black and Hispanic people with Hodgkin lymphoma across all ages.
-
Novel combination therapy for non-Hodgkin lymphoma in people and dogs
A new treatment combo using an oncolytic virus and other therapies is being tested to help people with hard-to-treat non-Hodgkin lymphoma, with studies also involving dogs to better understand responses.
-
Trajectories of Neurotoxicity in young Hodgkin lymphoma patients
Aging Hodgkin lymphoma patients who are adolescents or young adults may face long-lasting brain and nerve-related side effects from their cancer treatment, and this study aims to map how those problems develop over time.
-
Combination therapy approach for non-Hodgkin lymphoma (NHL)
A Mayo Clinic team is testing a new combination treatment for non-Hodgkin lymphoma to improve responses in patients and in dogs with similar disease.
-
Multi-antigen T cell therapy for relapsed NHL
A patient-derived T cell therapy called MT-601 targets six tumor-associated antigens to help treat relapsed non-Hodgkin lymphoma after other therapies may have failed.
-
Personalized de‑intensification of therapy for NLP Hodgkin lymphoma
A clinician-scientist at Stanford is developing a patient-centered program to tailor and reduce therapy for nodular lymphocyte-predominant Hodgkin lymphoma using tumor and blood samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.